So sell your holdings and quit complaining.
But, if you can hold on, do. August will
probably be looked back on as being "the
turning point". Parent's Alert ships this
month as far as I know. Chemtrak has some
nice plans for this product. And, keep
your fingers crossed, Astra-Merck should be
getting closer to giving the go-ahead. Plus,
ColoCARE is in distribution mode already, but
time will tell to see how that one does. The
results from last quarter were encouraging as
far as Cholestrak goes since the sales figures were,
for the most part reflecting Cholestrak sales.
So, look at it this way...at the end of 2nd quarter
Chemtrak had basically one product on the market.
At the end of the third quarter, that number should
hopefully be FOUR: Cholestrak, ColoCARE, Parent's
Alert, and HpChek. Still to come: 1) Theophylline
test, 2) the rapid HIV test, 3) AWARE (maybe. I wonder
if they will go forward with those plans.), and
4) anything we are not expecting. Remember, Ed Covell
had said that the company would be agressively seeking
out additional products to distribute for the
comsumer market. So, again. If you can hold out longer,
you probably will be glad you did. But if you are
not comfortable with the company, then by all means
sell.
Bill |
